CSL reported $97.21B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Arca Biopharma USD 2.43B 963M Mar/2026
aTyr Pharma USD 359M 351M Nov/2026
Bio Path USD 1000K 0 Mar/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Cara Therapeutics USD 30M 336M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Curis USD 22M 9M Mar/2026
Immunic USD 64M 23M Dec/2025